Benjamin L. Maughan

The University of Texas at San Antonio Health Science Center

Also affiliated with University of Utah, Huntsman Cancer Institute

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 18 papers. Top paper: “Prospective Evaluation of Bone Metabolic Markers as Surrogate Markers of Response to Radium-223 Therapy in Metastatic Castration-resistant Prostate Cancer”.

Prospective Evaluation of Bone Metabolic Markers as Surrogate Markers of Response to Radium-223 Therapy in Metastatic Castration-resistant Prostate Cancer

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-2591

N/A

1.2DataRank · unranked

26 citations

Roberto Nussenzveig, Andrew W. Hahn, John M. Hoffman, Kathryn A. Morton, Sumati Gupta +10 more

Creatine supplementation and resistance training to preserve muscle mass and attenuate cancer progression (CREATINE-52): a protocol for a double-blind randomized controlled trial

BMC Cancer(2024)10.1186/s12885-024-12260-3

N/A

0.278DataRank · unranked

4 citations

Lea Haverbeck Simon, Kelsey E. Maslana, Sarah Taylor, Kish Larson, Pamela A. Hansen +9 more

Pathogenic Germline DNA Repair Gene and HOXB13 Mutations in Men With Metastatic Prostate Cancer

JCO Precision Oncology(2020)10.1200/po.19.00284

N/A

0DataRank · unranked

13 citations

Andrew W. Hahn, Ashley L. Kapron, Wendy Kohlmann, Samantha Greenberg, Timothy J. Parnell +7 more

Association of serum iron and response to immune checkpoint inhibitors (ICIs) in metastatic clear cell renal cell carcinoma (mccRCC).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.723

N/A

0DataRank · unranked

0 citations

David D. Stenehjem, Neeraj Agarwal, Andrew W. Hahn, Deepika Sirohi, Prayushi Sharma +3 more

Treatment Pattern and Outcomes with Systemic Therapy in Men with Metastatic Prostate Cancer in the Real-World Patients in the United States

Cancers(2021)10.3390/cancers13194951

N/A

0DataRank · unranked

51 citations

Jennifer A. Sinnott, Benjamin Haaland, Nicolas Sayegh, Taylor Ryan McFarland, Nishita Tripathi +8 more

Identification of Somatic Gene Signatures in Circulating Cell-Free DNA Associated with Disease Progression in Metastatic Prostate Cancer by a Novel Machine Learning Platform

The Oncologist(2021)10.1002/onco.13869

N/A

0DataRank · unranked

16 citations

Andrew W. Hahn, Roberto Nussenzveig, Sergiusz Wesołowski, Nicolas Sayegh, Benjamin L. Maughan +11 more

Genomic predictors of response to PD-1 axis inhibitors in metastatic urothelial cancer (mUC) patients using machine learning analysis of tissue comprehensive genomic profiling (CGP).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.4542

N/A

0DataRank · unranked

0 citations

Víctor Sacristán Santos, Roberto Nussenzveig, Sergiusz Wesołowski, Edgar J. Hernández, Alexander Ryan Henrie +6 more

Impact of pretest video genetic education in prostate cancer patients: Do patients need us?

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.068

N/A

0DataRank · unranked

1 citations

Elizabeth Woelmer, Morgan Devlin, Sara Low, Amanda Anson, Wendy Kohlmann +12 more

Prostate-specific antigen value at 3 & 7 months (PSA-3mo, PSA-7mo) and overall survival (OS) in metastatic hormone-sensitive prostate cancer (mHSPC) treated with androgen deprivation (ADT) with or without orteronel (SWOG S1216).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.5074

N/A

0DataRank · unranked

2 citations

Catherine M. Tangen, Maha Hussain, Shilpa Gupta, Yeonjung Jo, Andrea Harzstark +15 more

Belzutifan for von Hippel–Lindau Disease: Pancreatic Lesion Population of the Phase 2 LITESPARK-004 Study

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-2592

N/A

0DataRank · unranked

28 citations

Eric Jonasch, Othon Iliopoulos, Kathryn E. Beckermann, Vivek Narayan, Benjamin L. Maughan +10 more

Three- and Seven-month Prostate-specific Antigen Levels as Prognostic Markers for Overall Survival in Metastatic Hormone-sensitive Prostate Cancer: Results from SWOG S1216, a Phase 3 Randomized Trial of Androgen Deprivation Plus Orteronel or Bicalutamide

European Urology Oncology(2024)10.1016/j.euo.2024.03.001

N/A

0DataRank · unranked

9 citations

Catherine M. Tangen, Maha Hussain, Shilpa Gupta, Sam Callis, Yeonjung Jo +17 more

Effectiveness of Second-Line Cabozantinib in Metastatic Clear Cell Renal Cell Carcinoma Patients After First-Line Treatment with Immune Checkpoint Inhibitor-based Combinations

Kidney Cancer(2024)10.3233/kca-240016

N/A

0DataRank · unranked

4 citations

Georges Gebrael, Yeonjung Jo, Vinay Mathew Thomas, Haoran Li, Gliceida Galarza Fortuna +11 more

Differences in Tumor Gene Expression Profiles Between De Novo Metastatic Castration-sensitive Prostate Cancer and Metastatic Relapse After Prior Localized Therapy

European Urology Oncology(2024)10.1016/j.euo.2024.04.013

N/A

0DataRank · unranked

1 citations

Nicolas Sayegh, Beverly Chigarira, Georges Gebrael, Nishita Tripathi, Roberto Nussenzveig +10 more

Real-world Effectiveness of Single-Agent Enfortumab Vedotin in Patients With Advanced Urothelial Carcinoma

Clinical Genitourinary Cancer(2024)10.1016/j.clgc.2024.102287

N/A

0DataRank · unranked

1 citations

Yeonjung Jo, Georges Gebrael, Nishita Tripathi, Beverly Chigarira, Ayana Srivastava +9 more

First-Line Ipilimumab with Nivolumab versus Immune Checkpoint Inhibitors with Tyrosine Kinase Inhibitors in Patients with Intermediate- or Poor-Risk Metastatic Clear Cell Renal Cell Carcinoma

Journal of Kidney Cancer and VHL(2025)10.15586/jkcvhl.v12i2.387

N/A

0DataRank · unranked

3 citations

Yeonjung Jo, Georges Gebrael, Chadi Hage Chehade, Zeynep İrem Özay, Blake Nordblad +11 more

Association of SPOP Mutations with Outcomes in Men with De Novo Metastatic Castration-sensitive Prostate Cancer

European Urology(2020)10.1016/j.eururo.2020.06.033

N/A

0DataRank · unranked

79 citations

Pedro Isaacsson Velho, Roberto Nussenzveig, Jonathan Chipman, Víctor Sacristán Santos, Stephanie Erickson +9 more

Corrigendum

Ophthalmology(2025)10.1016/j.ophtha.2024.12.032

N/A

0DataRank · unranked

0 citations

Ramaprasad Srinivasan, Jodi K. Maranchie, Jay Chhablani, Ane Bundsbæk Bøndergaard Iversen, A. Kruse +13 more

Tumor Frameshift Mutation Proportion Predicts Response to Immunotherapy in Mismatch Repair-Deficient Prostate Cancer

The Oncologist(2020)10.1002/onco.13601

N/A

0DataRank · unranked

58 citations

Julia Fountain, Pedro Isaacsson Velho, Su Jin Lim, Hao Wang, Emily Nizialek +15 more